Detecting Hidden
Cardiac Risks
Cardiac diseases are often already significantly advanced by the time symptoms appear.
DeepCardio's AI solution captures latent risk signals that are not yet externally visible, introducing disease prediction as a new approach to cardiac health management within today's prevention- and treatment-centered healthcare landscape.
MISSION & VISION
DeepCardio aims to contribute to healthier lives for all by leveraging AI to identify the likelihood of cardiac disease onset from ECG data.
-
MISSION
Expanding Cardiac Health with AI
We leverage AI technology to create earlier
opportunities for cardiac disease prevention.
-
MISSION
ECG Data Only
Rather than aggregating multiple data sources,
we analyze ECG data exclusively.
-
MISSION
Early Prediction, Healthy Lives
By enabling prevention before disease develops,
we contribute to healthier lives for all.
-
VISION
Full-Cycle Cardiac Solution
From routine screening to emergency care,
we can predict and diagnose all forms of cardiac disease.
-
VISION
Prevention Starting from Normal
We detect risk in ECGs that appear normal,
before symptoms ever emerge.
-
VISION
Cardiac-Specialized AI Solution
An AI solution that supports cardiologists'
clinical decisions by predicting cardiac risks before they manifest.
Full-Cycle Cardiac Solution
The Only Full-Cycle AI ECG Solution Company
DeepCardio is the only company that uses AI ECG technology to cover the full clinical spectrum of cardiac disease — from health screening centers to emergency settings. We have developed and launched solutions optimized for health screenings, outpatient care, and emergency environments, and are sequentially commercializing additional pipeline products. Through a full-cycle solution that enables diagnosis of diverse cardiac conditions from a single ECG test, we are building a future where anyone can quickly and accurately assess their cardiac health.
GLOBAL POSITIONING
AI ECG Technology Recognized in the Global Healthcare Market
In 2025, DeepCardio was
selected in the HealthTech 250 Prescriptive Analytics category among globally promising companies.
Our technology for predicting cardiac disease through AI ECG analysis,
combined with a system architecture that seamlessly adapts to real-world healthcare requirements,
is garnering recognition in the global healthcare market.
